Ryman Healthcare Limited (RYHTY)
OTCMKTS
· Delayed Price · Currency is USD
12.00
-0.57 (-4.53%)
Dec 20, 2024, 4:00 PM EST
Ryman Healthcare Cash Flow Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | -87.94 | 4.78 | 257.84 | 692.87 | 423.06 | 264.71 | Upgrade
|
| Depreciation & Amortization | 31.42 | 27.73 | 25.97 | 30.59 | 27.23 | 25.01 | Upgrade
|
| Other Amortization | 16.07 | 16.07 | 11.74 | 5.11 | 5.14 | 3.61 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 15.1 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | -49.13 | 64.03 | -420.47 | -745.89 | -416.85 | -144.44 | Upgrade
|
| Stock-Based Compensation | 2.94 | 2.93 | - | - | - | - | Upgrade
|
| Other Operating Activities | -12.64 | -162.85 | 103.22 | 33.28 | -31.62 | -91.25 | Upgrade
|
| Change in Accounts Receivable | 61.22 | 41.09 | -46.55 | -129.02 | -92.57 | -81.12 | Upgrade
|
| Change in Inventory | 6.48 | 12.23 | 11.63 | 0.39 | -26.74 | - | Upgrade
|
| Change in Accounts Payable | 7.78 | -2.65 | 41.11 | 9.17 | 4.85 | 5.51 | Upgrade
|
| Change in Unearned Revenue | 42.18 | 41.59 | 18.02 | 9.44 | 7.52 | 6.46 | Upgrade
|
| Change in Other Net Operating Assets | 589.45 | 613.55 | 639.43 | 680.03 | 498 | 461.31 | Upgrade
|
| Operating Cash Flow | 607.84 | 658.48 | 641.95 | 585.98 | 413.12 | 449.79 | Upgrade
|
| Operating Cash Flow Growth | -16.93% | 2.58% | 9.55% | 41.84% | -8.15% | 12.05% | Upgrade
|
| Capital Expenditures | -224.24 | -264.42 | -422.94 | -334.29 | -256.6 | -300.09 | Upgrade
|
| Sale of Property, Plant & Equipment | 22.41 | 15.28 | 19.65 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -9.51 | -15.48 | -20.11 | -14.35 | -9.46 | -9.71 | Upgrade
|
| Other Investing Activities | 5.88 | 5.12 | 1.2 | -4.28 | -0.92 | -2.07 | Upgrade
|
| Investing Cash Flow | -687.19 | -842.05 | -1,031 | -787.31 | -844.48 | -713.48 | Upgrade
|
| Long-Term Debt Issued | - | 201.22 | 436.72 | 326.92 | 566.87 | 421.87 | Upgrade
|
| Long-Term Debt Repaid | - | -3.37 | -752.12 | -2.66 | -39.19 | -1.91 | Upgrade
|
| Net Debt Issued (Repaid) | 64.87 | 197.85 | -315.4 | 324.26 | 527.69 | 419.96 | Upgrade
|
| Issuance of Common Stock | 3.76 | - | 2.64 | - | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -2.79 | -3.03 | -4.9 | Upgrade
|
| Common Dividends Paid | - | - | -68.09 | -112 | -107.5 | -117 | Upgrade
|
| Other Financing Activities | - | -0.35 | 769.44 | - | - | - | Upgrade
|
| Financing Cash Flow | 68.63 | 197.5 | 388.6 | 209.47 | 417.16 | 298.07 | Upgrade
|
| Net Cash Flow | -10.72 | 13.93 | -0.43 | 8.14 | -14.2 | 34.37 | Upgrade
|
| Free Cash Flow | 383.6 | 394.06 | 219.01 | 251.68 | 156.52 | 149.7 | Upgrade
|
| Free Cash Flow Growth | 1.03% | 79.93% | -12.98% | 60.80% | 4.56% | -32.01% | Upgrade
|
| Free Cash Flow Margin | 53.25% | 57.31% | 37.66% | 49.47% | 34.35% | 35.36% | Upgrade
|
| Free Cash Flow Per Share | 0.56 | 0.57 | 0.42 | 0.50 | 0.31 | 0.30 | Upgrade
|
| Cash Interest Paid | 60.94 | 33.6 | 46.86 | 29.24 | 18.57 | 19.05 | Upgrade
|
| Levered Free Cash Flow | 5,491 | 293.48 | 3,883 | -120.36 | -349.06 | -213.91 | Upgrade
|
| Unlevered Free Cash Flow | 5,558 | 337.43 | 3,881 | -101.2 | -336.96 | -201.84 | Upgrade
|
| Change in Net Working Capital | -5,760 | -575.68 | -4,285 | -207.48 | 120.78 | -50.93 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.